Clinical Trial Update: Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Proellex (telapristone acetate) for safety and efficacy in pre-menopausal anemic women with symptomatic uterine fibroids was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Uterine Fibroids

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids, Anemia | Phase 3 | Status: TERMINATED | Results posted: 2014-08-21